SBIR/STTR Recipient

Organos, Inc.

Brief Description Developer of cardiac micro physiological systems designed to offer three-dimensional (3D) human cardiac tissue models for advanced analysis. The company's data science ecosystem is used to illuminate the effects of compounds on human cardiac tissue, ranging from acute cardiotoxicity and safety pharmacology to chronic studies to predict drug-induced arrhythmia, thereby enabling the health industry to perform safer and cheaper drug development activities. Timeline 2016. Company founded. 2020. Company participated in Berkeley...

Nanosys

Brief Description SiNANOdeª, a silicon-graphite anode material, improves the performance of lithium-ion batteries: Significant increase over existing solutions in full cell energy density and cycle life. Manufacturing process compatible with existing graphite-anode electrode production equipment. Scalable SiNANOdeª production processes available now for technology transfer and licensing. Timeline 2001. Company founded 2023. Acquired by Shoei Chemical, as an operating subsidiary Inventors

Ali Shakouri, Arunava Majumdar, Peidong Yang, Yiying Wu...

Algen Biotechnologies

Brief Description

Algen Biotechnologies is building a next-generation, functional genomics-based platform for the discovery of novel therapeutics for cancers with high unmet need. Algen’s research group focuses on developing and applying novel functional genomics technologies to address scientific challenges in drug discovery. The company's biologists and data scientists are collaborating to deliver innovative, patient-centric medicines for the toughest-to-treat diseases.

The company was founded to commercialize technology developed at UC Berkeley while Algen Biotechnologies CEO...

Resvita Biosciences

Brief Description

Resvita Biosciences seeks to restore and maintain the vitality of the skin by properly considering the skin microbiome as part of the human body. A harmless skin probiotic will continuously deliver the therapy that a body would to maintain skin health.

Through synthetic biology and metabolic engineering, the company's goal is to develop a safe and versatile skin microbial platform that can address the causes of skin aging and disease. Resvita Biosciences has a unique patented approach, a rich product pipeline, clear regulatory advantages, and an experienced...

Monolets, Inc

Brief Description

MonoLets, Inc. is a systems company developing a wireless sensor network for the Internet of Things. The company builds the network with the lowest power System-on-Chip (SoC) hardware platform that can be operated from harvested energy requiring no external battery. The company's patented silicon and wireless mesh technology was developed over five years of research and development at UC Berkeley. Monolets' mission is to enable extremely reliable connectivity in challenging RF environments (metal & liquid obstruction), thereby providing access to real-time information...

Berkeley Yeast

Brief Description

Berkeley Yeast is a startup founded by UC Berkeley scientists, with grant funding from NSF, NIH, and USDA, as well as from venture capital. Berkeley Yeast bioengineers yeast strains that improve fermentation for brewers, winemakers, and beyond. The company uses synthetic biology to develop yeast strains with a variety of benefits, ranging from unprecedented control over flavors, to protection against the increasing vulnerability of crops, to greater product shelf stability and increased production efficiency. CEO Charles Denby co-founded the company based on the...

Fluxion Biosciences, Inc.

Brief Description

Fluxion Biosciences provides analytical, live cell analysis tools that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms in physiologically relevant micro-environments, Fluxion helps bridge the translational medicine gap by bringing research data closer to patients. Fluxion's innovative systems for live cell analysis are enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

The company successfully introduced three...

Lygos, Inc.

Brief Description

Lygos' technology goes beyond engineering microbes and includes fermentation and purification development. Our goal is to manufacture and sell chemicals. This work has been supported, in part, by over $6.5MM in grants from the U.S. Department of Energy, U.S. Department of Agriculture, and National Science Foundation.

Timeline 2011. Company founded Inventors

Jeffrey Fortman, Leonard Katz, Jay Keasling

Travertine Technologies

Brief Description

Travertine partners with mining and fertilizer operations around the world to recharge critical element production with a circular, electrified process. Standard mining methods use megatons of sulfuric acid annually, and dispose of vast amounts of byproducts, such as phosphorus, lithium, and nickel. The Travertine process upcycles sulfate byproducts into carbon-negative sulfuric acid and green hydrogen, while simultaneously and permanently sequestering CO2 from the air into carbonate minerals.

Travertine Founder and CEO Laura Lammers obtained a...

Lucira Health

Brief Description Lucira Health is revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing the tools necessary to empower people to become knowledgeable about their health. We produce inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in the world.

Formerly known as Diassess, Inc.

Lucira Health had an initial public offering on the Nasdaq stock exchange under the ticker symbol of LHDX...